Kristin R. Tompkins

机构：Pfizer (United States) · ORCID：0000-0003-0649-9335

发表论文 23 篇 · 总被引 6466 次 · h-index 15

代表论文

• Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates (2020 · New England Journal of Medicine · 被引 2748)
• Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (2020 · Nature · 被引 1599)
• BNT162b vaccines protect rhesus macaques from SARS-CoV-2 (2021 · Nature · 被引 762)
• SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 (2021 · New England Journal of Medicine · 被引 419)
• Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine (2023 · New England Journal of Medicine · 被引 177)
• RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study (2020 · medRxiv · 被引 157)